- 2024-08-20 01:45抑制剂ART558|ART558|2603528-97-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂ARS-1323-alkyne|ARS-1323-alkyne|2436544-27-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂ARS-1323-alkyne|ARS-1323-alkyne|2436544-27-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂ARS-1630|ARS-1630|1698055-86-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:45抑制剂ARS-1630|ARS-1630|1698055-86-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂ARP-100|ARP-100|704888-90-4|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:45抑制剂ARP-100|ARP-100|704888-90-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂ARP-100|ARP-100|704888-90-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂ARS-1323-alkyne|ARS-1323-alkyne|2436544-27-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:45抑制剂AR 231453|AR 231453|733750-99-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:45抑制剂AR 231453|AR 231453|733750-99-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂AR 231453|AR 231453|733750-99-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂Apostatin-1|Apostatin-1|2559703-06-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂APX-115 |APX-115 |1395946-75-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:45抑制剂APX-115 |APX-115 |1395946-75-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂APX-115 |APX-115 |1395946-75-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂Apitolisib|Apitolisib|1032754-93-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:45抑制剂Apostatin-1|Apostatin-1|2559703-06-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:45抑制剂Apostatin-1|Apostatin-1|2559703-06-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:45抑制剂APD597|APD597|897732-93-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
